Combination of a subcutaneous ICD in a patient with a baroreceptor activation device: Feasibility, safety, and precautions: A Case Report

We present a case of a patient with a baroreflex activation therapy (BAT) receiving a subcutaneous implantable cardioverter defibrillator (S‐ICD). We anticipated two possible hazardous interactions between the two devices. Stimulation by the BAT could be adjudicated as noise and result in underdetec...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 2017-12, Vol.40 (12), p.1486-1488
Main Authors: Kuffer, Liz, Steven, Daniel, Halbach, Marcel, Lüker, Jakob, den Bruck, Jan‐Hendrik, Sultan, Arian
Format: Article
Language:English
Subjects:
Adult
baroreceptor activation therapy
Baroreceptors
Cardiac arrhythmia
Case reports
Death, Sudden, Cardiac - prevention & control
Defibrillators
Defibrillators, Implantable - adverse effects
device interaction
Equipment Design
Feasibility Studies
heart failure
Humans
Implantable Neurostimulators
Male
Pressoreceptors
primary prevention of sudden cardiac death
Reflexes
subcutaneous ICD
Ventricle
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present a case of a patient with a baroreflex activation therapy (BAT) receiving a subcutaneous implantable cardioverter defibrillator (S‐ICD). We anticipated two possible hazardous interactions between the two devices. Stimulation by the BAT could be adjudicated as noise and result in underdetection of ventricular arrhythmias or it might be misinterpreted as ventricular arrhythmias and lead to inappropriate shocks. Postop ensing occurred, the upper limit of pulse width of the BAT was limited because of noise detection by the S‐ICD, but the upper limit of amplitude was limited by patient's discomfort. In this patient, the combination of a BAT and an S‐ICD was safe.
ISSN:0147-8389
1540-8159
DOI:10.1111/pace.13109